TOXICOLOGICAL ASSESSMENT OF THE NEW WOUND HEALING DRUG MAKLOZOL

The aim of the study is to comprehensively evaluate the acute and subchronic toxicity of the wound-healing gel Maclozol to determine its safe doses for use in veterinary practice. The studies were conducted on laboratory animals at the vivarium of the KSCZV. The reaction of laboratory rats to the administration of the drug and potential negative effects were studied. Acute toxicity was assessed with a single administration of the drug at a dose of 6000 mg/kg of body weight. An important aspect of research was the study of changes in the physiological state of laboratory rats, clinical signs such as animal activity, gastrointestinal tract function, as well as skin and coat condition. For a deeper understanding of the long-term effects of the use of the gel Maclozol, a subchronic toxicity study was conducted. During the experiment, three different dosages of the drug (600; 300 and 120 mg/kg) were used, as well as a placebo for 30 days. The tests conducted to determine the acute and subtoxic effects of the gel Maclozol established that the drug is safe. Observations showed a slight deterioration in the rats' condition immediately after administration due to manipulations, but the animals' condition recovered within 30–60 minutes. The animals' body weight gain in the subchronic experiment ranged from 8.4 to 8.8 % in the experimental groups. Activity remained high throughout the experiment. The absence of signs of diarrhea and the normal state of the gastrointestinal tract confirmed the absence of toxic effects. The use of the gel did not lead to any significant changes in the hematological and biochemical parameters of the animals compared to the control group. Long-term use of this wound healing agent is safe and does not cause toxic effects on the animal body. This made it possible to conclude that the levels of use of the drug for 30 days are safe. The Maklozol gel was classified as low-toxic and assigned to the 4th category (GOST 12.1.007-76 "Harmful substances. Classification and general safety requirements").

Authors

Institutions

Publication Details

Journal
Bulletin of KSAU
Published
2025-08-20
DOI
https://doi.org/10.36718/1819-4036-2025-7-161-170
Primary Topic
Bee Products Chemical Analysis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TOXICOLOGICAL ASSESSMENT OF THE NEW WOUND HEALING DRUG MAKLOZOL

A. A. Parfenyuk, А. М. Сампиев, Andrey Abramov
1 links
Bulletin of KSAU
Bee Products Chemical Analysis
article

TOXICOLOGICAL ASSESSMENT OF THE NEW WOUND HEALING DRUG MAKLOZOL

A. A. Parfenyuk, А. М. Сампиев, Andrey Abramov
article en

Abstract

The aim of the study is to comprehensively evaluate the acute and subchronic toxicity of the wound-healing gel Maclozol to determine its safe doses for use in veterinary practice. The studies were conducted on laboratory animals at the vivarium of the KSCZV. The reaction of laboratory rats to the administration of the drug and potential negative effects were studied. Acute toxicity was assessed with a single administration of the drug at a dose of 6000 mg/kg of body weight. An important aspect of research was the study of changes in the physiological state of laboratory rats, clinical signs such as animal activity, gastrointestinal tract function, as well as skin and coat condition. For a deeper understanding of the long-term effects of the use of the gel Maclozol, a subchronic toxicity study was conducted. During the experiment, three different dosages of the drug (600; 300 and 120 mg/kg) were used, as well as a placebo for 30 days. The tests conducted to determine the acute and subtoxic effects of the gel Maclozol established that the drug is safe. Observations showed a slight deterioration in the rats' condition immediately after administration due to manipulations, but the animals' condition recovered within 30–60 minutes. The animals' body weight gain in the subchronic experiment ranged from 8.4 to 8.8 % in the experimental groups. Activity remained high throughout the experiment. The absence of signs of diarrhea and the normal state of the gastrointestinal tract confirmed the absence of toxic effects. The use of the gel did not lead to any significant changes in the hematological and biochemical parameters of the animals compared to the control group. Long-term use of this wound healing agent is safe and does not cause toxic effects on the animal body. This made it possible to conclude that the levels of use of the drug for 30 days are safe. The Maklozol gel was classified as low-toxic and assigned to the 4th category (GOST 12.1.007-76 "Harmful substances. Classification and general safety requirements").

Bulletin of KSAUVol. 0(7)
Animal Husbandry & Veterinary (IN), Krasnoyarsk Research Institute of Animal Husbandry (RU)
Good health and well-being
Openalex Percentile: Top 80%
Bee Products Chemical Analysis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.